Autologous haemopoietic stem cell transplantation for autoimmune diseases

Expert Opinion on Biological Therapy

Volumn 11, Issue 9, 2011, Pages 1193-1201

  Zeher, Margit ^a   Papp, Gabor ^a   Szodoray, Peter ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Autoimmune diseases; Autologous hemopoietic stem cell transplantation; Clinical response; Immunological background

Indexed keywords

ABATACEPT; C PEPTIDE; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GADOLINIUM; HEMOGLOBIN A1C; INTERFERON; MITOXANTRONE; RITUXIMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHRONIC DEMYELINATING INFLAMMATORY POLYNEUROPATHY; CLINICAL PROTOCOL; CORTICOSTEROID THERAPY; CROHN DISEASE; DEMYELINATING DISEASE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; MULTIPLE SCLEROSIS; MYELODYSPLASTIC SYNDROME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PANCREAS ISLET BETA CELL; PATIENT SELECTION; POLYNEUROPATHY; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; AUTOIMMUNE DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION, AUTOLOGOUS;

ANIMALIA;

EID: 80051482080     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2011.580272     Document Type: Review

References (67)

1. Thewissen M, Stinissen P. New concepts on the pathogenesis of autoimmune diseases: a role for immune homeostasis, immunoregulation, and immunosenescence. Crit Rev Immunol 2008;28:363-76
2. St Clair EW. Novel targeted therapies for autoimmunity. Curr Opin Immunol 2009;21:648-57
3. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005;435:620-7 (Pubitemid 40825502)
4. Knaan-Shanzer S, Houben P, Kinwel-Bohre EP, et al. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991;8:333-8
5. Szodoray P, Varoczy L, Szegedi G, Zeher M. Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications. Scand J Rheumatol 2010;39:1-11
6. Bingham S, Veale D, Fearon U, et al. High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis Rheum 2002;46:837-9 (Pubitemid 34214267)
7. Muraro PA, Douek DC, Packer A, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005;201:805-16 (Pubitemid 40395124)
8. Mackall CL, Bare CV, Granger LA, et al. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996;156:4609-16 (Pubitemid 26174440)
9. Herrmann MM, Gaertner S, Stadelmann C, et al. Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood 2005;106:1875-83 (Pubitemid 41208608)
10. Roord ST, de Jager W, Boon L, et al. Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3 + regulatory T cells. Blood 2008;111:5233-41
11. de Kleer I, Vastert B, Klein M, et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006;107:1696-702 (Pubitemid 43242411)
12. Farge D, Labopin M, Tyndall A, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 2010;95:284-92
13. Torres A, Askari AD, Malemud CJ. Cardiovascular disease complications in systemic lupus erythematosus. Biomark Med 2009;3:239-52
14. Burt RK, Traynor A, Statkute L, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006;295:527-35 (Pubitemid 43200347)
15. Pavletic SZ, Illei GG. The role of immune ablation and stem cell transplantation in severe SLE. Best Pract Res Clin Rheumatol 2005;19:839-58 (Pubitemid 41258586)
16. Marmont AM, Burt RK. Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases. Autoimmunity 2008;41:639-47
17. Jayne D, Passweg J, Marmont A, et al.; European Group for Blood and Marrow Transplantation; European League Against Rheumatism Registry. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004;13:168-76 (Pubitemid 38478643)
18. Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol 2005;26:587-95 (Pubitemid 41726446)
19. Papp G, Horvath I, Barath S, et al. Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis. Scand J Rheumatol 2011;40:205-10
20. Radstake TR, van Bon L, Broen J, et al. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One 2009;4:e5903
21. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6
22. Farge D, Passweg J, van Laar JM, et al.; EBMT/EULAR Registry. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis 2004;63:974-81 (Pubitemid 38961924)
23. Farge D, Henegar C, Carmagnat M, et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum 2005;52:1555-63 (Pubitemid 40663947)
24. Nash RA, McSweeney PA, Nelson JL, et al. Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis. Arthritis Rheum 2006;54:1982-6 (Pubitemid 43877948)
25. Nash RA, McSweeney PA, Crofford LJ, et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 2007;110:1388-96 (Pubitemid 47281441)
26. Miniati I, Guiducci S, Conforti ML, et al. Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Ann Rheum Dis 2009;68:94-8
27. Ratts RB, Karandikar NJ, Hussain RZ, et al. Phenotypic characterization of autoreactive T cells in multiple sclerosis. J Neuroimmunol 2006;178:100-10 (Pubitemid 44354819)
28. Uccelli A, Mancardi G. Stem cell transplantation in multiple sclerosis. Curr Opin Neurol1 2010;23:218-25
29. Saiz A, Blanco Y, Carreras E, et al. Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology 2004;62:282-4 (Pubitemid 38167140)
30. Saccardi R, Kozak T, Bocelli-Tyndall C, et al. Autoimmune Diseases Working Party of EBMT. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation Autoimmune Diseases Working Party Database. Mult Scler 2006;12:814-23 (Pubitemid 46111776)
31. Mancardi GL, Murialdo A, Rossi P, et al. Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. Mult Scler 2005;11:367-71 (Pubitemid 40775198)
32. Kimiskidis V, Sakellari I, Tsimourtou V, et al. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome. Mult Scler 2008;14:278-83 (Pubitemid 351639644)
33. Burt RK, Loh Y, Cohen B, et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a Phase I/II study. Lancet Neurol 2009;8:244-53
34. Fagius J, Lundgren J, Oberg G. Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation. Mult Scler 2009;15:229-37
35. Snowden JA, Passweg J, Moore JJ, et al. Autologous hematopoietic stem cell transplantation in severe rheumatoid arthritis. J Rheumatol 2004;31:482-8 (Pubitemid 38337605)
36. Tyndall A, Saccardi R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from Phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol 2005;141:1-9 (Pubitemid 40904634)
37. Verburg RJ, Kruize AA, van den Hoogen FH, et al. High dose chemotherapy and autologous stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety and efficacy. Arthritis Rheum 2001;44:754-60 (Pubitemid 32319767)
38. Passweg J, Tyndall A. Autologous stem cell transplantation in autoimmune diseases. Semin Hematol 2007;44:278-85 (Pubitemid 47599541)
39. Barron KS, Wallace C, Woolfrey CEA, et al. Autologous stem cell transplantation for pediatric rheumatic diseases. J Rheumatol 2001;28:2337-58 (Pubitemid 32947886)
40. Wulffraat NM, de Kleer IM, Prakken BJ, Kuis W. Stem cell transplantation for autoimmune disorders. Refractory juvenile idiopathic arthritis. Best Pract Res Clin Haematol 2004;17:277-89
41. Brinkman DM, de Kleer IM, ten Cate R, et al. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Arthritis Rheum 2007;56:2410-21 (Pubitemid 47173589)
42. Daikeler T, K€otter I, Bocelli Tyndall C, et al. EBMT Autoimmune Diseases Working Party. Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature. Ann Rheum Dis 2007;66:202-7 (Pubitemid 46226055)
43. Statkute L, Oyama Y, Barr WG, et al. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis. Ann Rheum Dis 2008;67:991-7 (Pubitemid 351956663)
44. Maurer B, Hensel M, Max R, et al. Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up. Ann Rheum Dis 2006;65:127-9 (Pubitemid 41815655)
45. Rao VK, Price S, Perkins K, et al. Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS). Pediatr Blood Cancer 2009;52:847-52
46. Dryden GW. Overview of stem cell therapy for Crohn's disease. Expert Opin Biol Ther 2009;9:841-7
47. Burt RK, Craig RM, Milanetti F, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood 2010;116:6123-32
48. Cassinotti A, Annaloro C, Ardizzone S, et al. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease. Gut 2008;57:211-17 (Pubitemid 351158049)
49. Vermeulen M, Van Oers MH. Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002;72:127-8 (Pubitemid 34073115)
50. Mahdi-Rogers M, Kazmi M, Ferner R, et al. Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy. J Peripher Nerv Syst 2009;14:118-24
51. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010;464:1293-300
52. Milanetti F, Abinun M, Voltarelli JC, Burt RK. Autologous hematopoietic stem cell transplantation for childhood autoimmune disease. Pediatr Clin North Am 2010;57:239-71
53. Voltarelli JC, Couri CE, Stracieri AB, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007;297:1568-76 (Pubitemid 46588370)
54. Couri CE, Oliveira MC, Stracieri AB, et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2009;301:1573-9
55. Miltenyi S. CD34+ selection: the basic component for graft engineering. Oncologist 1997;2:410-3 (Pubitemid 28028596)
56. Burt RK, Marmont A, Oyama Y, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006;54:3750-60 (Pubitemid 44955875)
57. Euler HH, Marmont AM, Bacigalupo A, et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996;88:3621-5 (Pubitemid 26365601)
58. Moore J, Brooks P, Milliken S, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002;46:2301-9
59. Bohgaki T, Atsumi T, Koike T. Autoimmune disease after autologous hematopoietic stem cell transplantation. Autoimmun Rev 2008;7:198-203
60. Gilliland DG, Gribben JG. Evaluation of the risk of therapy-related MDS/AML after autologous stem cell transplantation. Biol Blood Marrow Transplant 2002;8:9-16 (Pubitemid 34141546)
61. Northwestern University. Stem Cell Therapy for Patients With Multiple Sclerosis Failing Interferon. A Randomized Study. ClinicalTrials.gov NCT00273364. Available from: http://clinicaltrials.gov/ct2/show/NCT00273364? term=NCT00273364&rank=1
62. Charite University, Berlin, Germany, Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST). ClinicalTrials. gov NCT00750971. Available from: http://clinicaltrials.gov/ct2/show/NCT0075097?term= NCT00750971& rank=1
63. European Group for Blood and Marrow Transplantation. ASTIC Autologous Stem Cell Transplantation for Crohn's Disease. ClinicalTrials.gov NCT00297193. Available from: http://clinicaltrials.gov/ct2/show/NCT00297193? term=NCT00297193&rank=1
64. Autologous Stem cell Transplantation International Multiple Sclerosis. European Group for Blood and Marrow Transplantation (EBMT). Available from: www.astims.org [Last accessed 18 April 2011]
65. Autologous Stem Cell Transplantation International Scleroderma Trial (ASTIS). Middlesbrough, Teesside, UK: EBMT/EULAR Scleroderma Study Group, 2008. Available from: http://www. astistrial.com/
66. Northwestern University. Crohn's Disease Stem Cell Transplantation. ClinicalTrials.gov NCT00271947. Available from: http://clinicaltrials.gov/ct2/ show/NCT00271947?term= NCT00271947&rank=1
67. National Institute of Allergy and Infectious Diseases (NIAID). Scleroderma: Cyclophosphamide or Transplantation (SCOT). ClinicalTrials. gov NCT00114530 Available from: http://clinicaltrials.gov/ct2/show/NCT00114530?term= NCT00114530& rank=1